Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
Published in: The Lancet
Date of publication: April 1, 2007
Language: English
Main subject: phase II clinical trial, patient, multiple drug resistance, raltegravir
Bibliographic databases:
Cites articles 12
- March 1, 2003
- May 1, 2005
Date
Title
Article -